1. Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy

   • Gregory B. Lesinski
   • Daniel Valentino
   • William E. Carson III

   Original Article 25 January 2005 Pages: 815 - 825

   

2. Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy

   • Tobias Krüger
   • Oliver Schoor
   • Stefan Stevanović

   Original Article 31 December 2004 Pages: 826 - 836

   

3. Role of tumor-derived transforming growth factor-β1 (TGF-β1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma

   • V. S. Thakur
   • B. Shankar
   • K. B. Sainis

   Original Article 23 February 2005 Pages: 837 - 847

   

4. Phase I study of TNFα AutoVaccIne in Patients with metastatic cancer

   • A. M. Waterston
   • L. Gumbrell
   • R. C. Coombes

   Original Article 08 March 2005 Pages: 848 - 857

   

5. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

   • Jose Manuel Cózar
   • Julia Canton
   • Francisco Ruiz-Cabello Osuna

   Original Article 11 May 2005 Pages: 858 - 866

   

6. Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes

   • Kfir Oved
   • Avital Lev
   • Yoram Reiter

   Original Article 20 May 2005 Pages: 867 - 879

   

7. Exposure to the electrofusion process can increase the immunogenicity of human cells

   • Barry D. Hock
   • Georgina Roberts
   • Justin A. Roake

   Original Article 31 May 2005 Pages: 880 - 890

   

8. Sustained low-level expression of interferon-γ promotes tumor development: potential insights in tumor prevention and tumor immunotherapy

   • Yu-Fei He
   • Xiao-Hong Wang
   • Zuo-Hua Feng

   Original Article 18 March 2005 Pages: 891 - 897

   

9. Transforming growth factor-β₁ immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system

   • Florian Weber
   • Scott N. Byrne
   • Gary M. Halliday

   Original Article 18 March 2005 Pages: 898 - 906

   

10. Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo

    • Jia-Hai Ma
    • Yan-Fang Sui
    • Xiu-Min Zhang

    Original Article 09 March 2005 Pages: 907 - 914

    

11. Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

    • Janet M. D. Plate
    • Aileen E. Plate
    • Jules E. Harris

    Original Article 22 March 2005 Pages: 915 - 925

    

12. Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study

    • J. M. Kerst
    • A. Bex
    • G. C. de Gast

    Original Article 19 May 2005 Pages: 926 - 931